OvaScience Reports Fourth Quarter and Year End 2014 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
OvaScience (OVAS) Bullish Stance Reiterated at Leerink Partners Post Q4
March 17, 2015 6:35 AM EDTLeerink Partners analyst Gena Wang reiterated an Outperform rating and $56 price target on OvaScience (NASDAQ: OVAS) following Q4 results, noting the AUGMENT commercial launch is on track, with pipeline assets providing upside.
Wang commented, "While no commercial cycles reported in 4Q:14,... More
Ovascience (OVAS) Misses Q4 EPS by 20c
March 16, 2015 4:34 PM EDTOvascience (NASDAQ: OVAS) reported Q4 EPS of ($0.79), $0.20 worse than the analyst estimate of ($0.59).
For earnings history and earnings-related data on Ovascience (OVAS) click here.
... More